ClinicalTrials.gg
RecruitingNCT07302906SOARUpdated Nov 16, 2026

Ambient AI Scribe (Voa Health) in Outpatient Clinics: Draft Notes, Documentation Burden, and Well-Being

An interventional study of Ambient AI scribe for clinical documentation (Voa Health) and Usual documentation without AI scribe (standard care) in Burnout, Professionals, Medical Records Systems, Computerized and Physician-Patient Relations, sponsored by Pedro Angelo Basei de Paula. Recruiting at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Pedro Angelo Basei de Paula · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Jan 2025, registered Dec 2025).
  • Started Jan 2025; still recruiting 1 year 10 months later.
Updated Nov 16, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this randomized clinical trial is to learn whether an "ambient AI scribe" (Voa Health) can reduce documentation burden and improve physician well-being and patient experience in outpatient clinics. The AI scribe listens to the audio of the consultation and produces a draft of the clinical note that the physician reviews and edits.

In this study, consultations are randomized to 2 groups: usual documentation (without AI) or documentation assisted by the AI scribe. Adult patients seen in participating clinics, and their physicians, are invited to take part. For both groups, the consultation audio is recorded and, at the end of the visit, physicians and patients complete short questionnaires about well-being, workload, communication, empathy, and satisfaction. The questionnaires are based on internationally used scales (such as PFI, Mini-Z, NASA-TLX, CARE, PSQ-18, and CAT) but adapted to keep them brief and feasible in routine care.

The main questions are whether the AI scribe lowers the time and effort needed to document the visit, improves physician professional fulfillment and reduces burnout, and whether it affects how patients perceive the communication, empathy, and overall quality of the consultation. No drugs or devices are being tested. The results are expected to guide hospitals on the safe and effective use of ambient AI scribes in real-world clinical practice.

Read the detailed description

This study is a randomized controlled trial designed to assess the impact of an ambient artificial-intelligence (AI) scribe on physician well-being, documentation workload, and patient experience in routine outpatient care.

The intervention consists of using the Voa Health ambient AI scribe during clinical encounters. The system records the audio of the consultation and generates a structured draft clinical note in real time, aligned with specialty-specific templates that reflect the routine workflow of each clinic (for example, different templates for general cardiology, heart failure, dyslipidemia, etc.). At the end of the visit, the physician reviews, edits, and signs the draft in the electronic medical record (EMR), remaining fully responsible for the accuracy and completeness of the documentation. In the control condition, physicians conduct consultations and document encounters using their usual methods without AI support. For study purposes, audio may still be recorded in the control arm, but no AI-generated note is displayed or used by the clinician.

The unit of randomization is the individual consultation. For participating physicians, eligible visits are automatically allocated to one of two parallel arms: (1) usual documentation without AI and (2) documentation assisted by the ambient AI scribe. Randomization is designed to preserve the existing organization of each clinic and to avoid interference with scheduling or patient flow. Clinical care, diagnostic and therapeutic decisions, and follow-up procedures are not dictated by the protocol and follow usual practice; the only experimental element is the use (or non-use) of the AI scribe for documentation and the collection of audio and questionnaires.

Adult patients seen in participating outpatient clinics, and their physicians, are invited to take part. After informed consent, the entire consultation is audio-recorded. Immediately after each visit, both patient and physician are asked to complete brief, structured questionnaires that capture the main outcomes of interest. To keep data collection feasible in a busy ambulatory setting, the instruments were built from subsets of items derived from internationally used scales, while keeping the number of questions per consultation small.

For physicians, items are drawn from the Professional Fulfillment Index (PFI), the Mini-Z 2.0 survey, and the 4-item Physician Task Load / NASA-TLX. These items assess professional fulfillment and burnout (physical and emotional exhaustion), perceived sufficiency of time for documentation, work in the EMR outside direct patient contact, perceived documentation burden, and temporal demand of the visit. Additional study-specific items evaluate the perceived quality and completeness of the final note, time required to edit the AI-generated draft, confidence that key clinical details were captured, occurrence of potential AI "hallucinations" (information not actually stated in the visit), and the perceived impact of documentation on attention to the patient.

For patients, questionnaires use items derived from the Consultation and Relational Empathy (CARE) Measure, the Patient Satisfaction Questionnaire Short-Form (PSQ-18), and the Communication Assessment Tool (CAT). These items cover domains such as active listening, understanding of patient concerns, clarity of explanations, adequacy of time spent with the physician, perceived empathy, overall satisfaction with care, and understanding of diagnosis and treatment. In the AI arm, one additional item specifically asks whether the use of AI during the consultation helped, did not change, or hindered the clarity of communication with the physician.

The primary outcomes are physician-reported well-being and perceived documentation workload when using the ambient AI scribe compared with usual documentation. Key secondary outcomes include patient-reported experience and satisfaction, physician-rated quality and completeness of notes, time required for documentation and for editing AI-generated drafts, and the frequency and clinical relevance of AI-related documentation errors or hallucinations. All outcomes are measured at the level of the individual consultation, immediately after each visit.

The trial is initially conducted in multiple outpatient clinics of Hospital de Clínicas of the Federal University of Paraná (UFPR), Brazil, across different medical specialties. In each service, structured note templates are developed in collaboration with local clinical leaders so that the AI-generated drafts reflect the real-world flow of that specialty without changing the standard of care. Medical students and residents trained in the protocol may support consent and questionnaire administration under supervision of attending physicians, to ensure consistent and feasible data collection.

Data are stored in secure, access-controlled servers, with linkage between audio recordings, questionnaires, and EMR notes managed through coded identifiers. A data monitoring committee, independent from the development team of the AI scribe, periodically reviews aggregated data for protocol adherence, data quality, and any safety concerns related to the use of AI in documentation (for example, systematic documentation errors that could potentially affect patient care). Because the intervention is limited to documentation support and clinicians remain responsible for all clinical decisions and for finalizing the notes, the overall risk of participation is considered minimal.

The protocol allows for future expansion to other outpatient services and collaborating centers that adopt the same randomization, data collection procedures, and outcome definitions. The results are expected to provide pragmatic evidence on how ambient AI scribes can be implemented safely and effectively in real-world clinical practice, particularly regarding their impact on physician well-being, documentation workload, and the patient's experience of the consultation.

02

Conditions studied

  • Burnout, Professionals
  • Medical Records Systems, Computerized
  • Physician-Patient Relations
  • Ambulatory Care

Keywords

  • ambient AI scribe
  • artificial intelligence
  • clinical documentation
  • medical note generation
  • electronic health record
  • physician well-being
  • documentation burden
  • patient experience
  • outpatient clinics
  • randomized controlled trial
03

In context

Burnout, Psychological

468 studies on the registry are indexed under Burnout, Psychological; 121 are open to participants now.

This study's planned enrollment of 300 is above the median of 80 across 344 interventional studies indexed under Burnout, Psychological.

Browse Burnout, Psychological studies →

Lead sponsor

This is the only study on the registry with Pedro Angelo Basei de Paula as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Patients:

  1. Adults (≥18 years) attended at the participating outpatient clinics of the Hospital de Clínicas - Federal University of Paraná during the study period.
  2. Under the care of a physician participating in the trial.
  3. Ability to understand Portuguese and provide for the audio recording of the consultation and completion of brief questionnaires.
  4. Ability to complete post-consultation questionnaires during interview.

Physicians:

  1. Resident physicians working in the participating outpatient clinics.
  2. Use of the hospital's electronic medical record in routine care practice.
  3. Agreement to the audio recording of consultations and to the completion of brief questionnaires after each included encounter.

Student Researchers:

  1. Medical students or undergraduate health science students linked to the research project.
  2. Trained in patient registration, collection of Informed Consent (ICF), and administration of questionnaires to the patient on the Infinity Research platform.

Exclusion criteria

Exclusion Criteria:

  1. Patients under 18 years of age.
  2. Emergency consultations, urgent care, or inpatient care.
  3. Patients with significant cognitive impairment, acute distress, or clinical instability that, in the opinion of the treating physician, precludes providing consent or completing questionnaires, except when accompanied by a legal guardian capable of providing consent on their behalf.
  4. Patients under legal guardianship or who, for any reason, cannot provide consent on their own, except when the guardian or legal representative is present and can provide .
  5. Consultations where either the patient or the physician refuses audio recording or participation in the study.
  6. Consultations where the AI system is unavailable or malfunctioning (applicable only for protocol adherence analyses).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    Ambient AI scribe (Voa Health)

    Outpatient consultations in which the Voa Health ambient AI scribe is active. The system records the audio of the visit and generates a structured draft clinical note based on specialty-specific templates. The physician reviews, edits, and signs the note in the EMR. After the visit, the physician and the patient complete brief questionnaires about workload, well-being, communication, empathy, and satisfaction.

    Other: Ambient AI scribe for clinical documentation (Voa Health)

  • Active comparator
    Usual documentation without AI scribe

    Outpatient consultations in which documentation is performed using usual methods without AI support (standard clinical practice). Audio of the visit may be recorded for study purposes, but no AI-generated note is shown to the clinician. After the visit, the physician and the patient complete the same brief questionnaires about workload, well-being, communication, empathy, and satisfaction.

    Other: Usual documentation without AI scribe (standard care)

Interventions

  • OtherAmbient AI scribe for clinical documentation (Voa Health)

    Use of an ambient artificial-intelligence (AI) scribe during outpatient consultations. The Voa Health system records the audio of the visit and generates a structured draft clinical note based on specialty-specific templates that follow the usual flow of each clinic. After the consultation, the physician reviews, edits, and signs the note in the electronic medical record. The AI does not make diagnostic or therapeutic decisions; it only assists documentation. All other aspects of clinical care follow routine practice.

  • OtherUsual documentation without AI scribe (standard care)

    Clinical documentation performed using usual methods without AI support (standard care). Physicians document the encounter in the electronic medical record as they normally do (typing, dictation, or handwritten notes as applicable). Audio of the visit may be recorded for study purposes, but no AI-generated draft note is shown to the clinician. After the consultation, physicians and patients complete the same brief questionnaires about workload, well-being, communication, empathy, and satisfaction.

06

What researchers measure

Primary outcomes

  1. Physician documentation workload during the visit

    Physician-reported documentation burden, measured immediately after each consultation using brief 5-point Likert-type items adapted from internationally used instruments (NASA-TLX, Mini-Z) and study-specific items. Items assess: (1) administrative burden of the consultation, (2) time available to focus on the patient, (3) mental demand of the consultation (adapted NASA-TLX), (4) interference of the documentation process with patient interaction, and (5) disruption of workflow due to documentation adjustments. Individual item scores and a composite burden score (mean of items; higher values = greater burden) will be compared between consultations with the ambient AI scribe and consultations with usual documentation without AI.

    Time frame: Immediately after each outpatient consultation (same day)

  2. Physician well-being / exhaustion during the visit

    Physician physical exhaustion immediately after the consultation, assessed with a single item derived from the Professional Fulfillment Index (PFI): "I feel physically exhausted after this consultation," rated on a 5-point agreement scale (strongly disagree to strongly agree; higher values = greater exhaustion). Scores will be compared between consultations with the ambient AI scribe and consultations with usual documentation without AI.

    Time frame: Immediately after each outpatient consultation (same day)

Secondary outcomes

  1. Patient experience of communication and empathy

    Patient-reported experience of the consultation, including active listening, understanding of concerns, clarity of explanations, perceived empathy, time spent with the physician, and overall satisfaction. Items are derived from the CARE Measure, PSQ-18, and Communication Assessment Tool (CAT), rated on 5-point Likert scales. A composite score (mean of item scores; higher values = better experience) will be compared between consultations with the ambient AI scribe and consultations with usual documentation without AI.

    Time frame: Immediately after each outpatient consultation (same day)

  2. Patient understanding of diagnosis and treatment

    Single item asking patients how much they understood about their diagnosis and treatment after the consultation, rated on a 5-point scale from 1 (nothing) to 5 (completely). Scores will be compared between consultations with the ambient AI scribe and consultations with usual documentation without AI.

    Time frame: Immediately after each outpatient consultation (same day)

  3. Physician-rated quality and completeness of clinical notes

    Physician global rating of the final clinical note for the consultation (clarity, organization, and completeness), using a 5-point scale adapted from Mini-Z (poor, marginal, satisfactory, good, excellent). Scores will be compared between consultations with the ambient AI scribe and consultations with usual documentation without AI.

    Time frame: Immediately after finalizing documentation for each consultation (same day)

  4. Time required for documentation outside direct patient contact

    Physician self-reported time spent working on the electronic medical record outside direct patient contact for that consultation (for example, after the patient leaves the room), including review and editing of AI-generated notes when applicable. Time is rated in ordered categories (almost none; minor edits; moderate edits; extensive edits). Distributions of categories will be compared between the ambient AI scribe and usual documentation conditions.

    Time frame: Immediately after each outpatient consultation (same day)

  5. Proportion of consultations with AI-related hallucinations in documentation

    Among consultations in the ambient AI scribe arm, physicians indicate whether the AI inserted any information in the draft note that was not actually mentioned in the consultation. The outcome is the proportion of AI-assisted consultations with at least one reported hallucination.

    Time frame: Immediately after each AI-assisted consultation (same day)

  6. Proportion of clinical notes with documentation errors in blinded external review

    De-identified clinical notes from both study arms (AI scribe and usual documentation) will be randomly mixed and independently reviewed by at least two clinicians who are blinded to group allocation. Reviewers will classify whether each note contains any clinically relevant documentation error, including fabricated or incorrect information ("hallucinations") that does not match the plausible content of a standard outpatient visit. The primary variable is the proportion of notes with at least one such error in each arm; proportions will be compared between AI-scribe and usual documentation conditions.

    Time frame: Within 30 days after finalizing each clinical note

07

Study locations

1 of 1 sites recruiting
  • Complexo Hospital de Clínicas da UFPR (CHC-UFPR)
    Curitiba, Paraná 80060-900, Brazil
    Recruiting
08

References and documents

Publications

  • Afshar M, Baumann MR, Resnik F, Hintzke J, Sullivan AG, Wills G, Lemmon K, Dambach J, Ann Mrotek L, Quinn M, Abramson K, Kleinschmidt P, Brazelton TB, Leaf MA, Twedt H, Kunstman D, Patterson B, Liao F, Rasmussen S, Burnside ES, Goswami C, Gordon J. A Pragmatic Randomized Controlled Trial of Ambient Artificial Intelligence to Improve Health Practitioner Well-Being. NEJM AI. 2025 Dec;2(12):10.1056/aioa2500945. doi: 10.1056/aioa2500945. Epub 2025 Nov 26. PubMed 41625485 ↗
  • Grace Hong, B.A., Lauren Wilcox, Ph.D., Amelia Sattler, M.D., Samuel Thomas, M.D., Nina Gonzalez, M.D., Marissa Smith, Ph.D., John Hernandez, Ph.D., Margaret Smith, M.B.A., Steven Lin, M.D., and Robert Harrington, M.D. Clinicians' Experiences with EHR Documentation and Attitudes Toward AI-Assisted Documentation. Stanford University School of Medicine and Google Health. 2020.
  • Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Future Healthc J. 2019 Jun;6(2):94-98. doi: 10.7861/futurehosp.6-2-94. PubMed 31363513 ↗
  • Quiroz JC, Laranjo L, Kocaballi AB, Berkovsky S, Rezazadegan D, Coiera E. Challenges of developing a digital scribe to reduce clinical documentation burden. NPJ Digit Med. 2019 Nov 22;2:114. doi: 10.1038/s41746-019-0190-1. eCollection 2019. PubMed 31799422 ↗
  • Cheng CG, Wu DC, Lu JC, Yu CP, Lin HL, Wang MC, Cheng CA. Restricted use of copy and paste in electronic health records potentially improves healthcare quality. Medicine (Baltimore). 2022 Jan 28;101(4):e28644. doi: 10.1097/MD.0000000000028644. PubMed 35089204 ↗
  • Olson KD, Meeker D, Troup M, Barker TD, Nguyen VH, Manders JB, Stults CD, Jones VG, Shah SD, Shah T, Schwamm LH. Use of Ambient AI Scribes to Reduce Administrative Burden and Professional Burnout. JAMA Netw Open. 2025 Oct 1;8(10):e2534976. doi: 10.1001/jamanetworkopen.2025.34976. PubMed 41037268 ↗
  • Yixing Jiang, Kameron C. Black, D.O., M.P.H., Gloria Geng, Danny Park, James Zou, Ph.D., Andrew Y. Ng, Ph.D., and Jonathan H. Chen, M.D., Ph.D. MedAgentBench: A Virtual EHR Environment to Benchmark Medical LLM Agents. NEJM AI. August 14, 2025;2(9)
  • Afshar M, Resnik F, Baumann MR, Hintzke J, Lemmon K, Sullivan AG, Shah T, Stordalen A, Oberst M, Dambach J, Mrotek LA, Quinn M, Abramson K, Kleinschmidt P, Brazelton T, Twedt H, Kunstman D, Wills G, Long J, Patterson BW, Liao FJ, Rasmussen S, Burnside E, Goswami C, Gordon JE. A Novel Playbook for Pragmatic Trial Operations to Monitor and Evaluate Ambient Artificial Intelligence in Clinical Practice. NEJM AI. 2025 Sep;2(9):10.1056/aidbp2401267. doi: 10.1056/aidbp2401267. Epub 2025 Aug 28. PubMed 40959192 ↗
  • BASEI DE PAULA, P., BRUNETI SEVERINO, J., BERGER, M., VEIGA, M., PARENTE RIBEIRO, K., LOURES, F., TODESCHINI, S., ROEDER, E., MARQUES, G.. Improving documentation quality and patient interaction with AI: a tool for transforming medical records-an experience report. Journal of Medical Artificial Intelligence, North America, 8, jan. 2025. Available at: <https://jmai.amegroups.org/article/view/9651>
  • Lukac PJ, Turner W, Vangala S, Chin AT, Khalili J, Shih YT, Sarkisian C, Cheng EM, Mafi JN. Ambient AI Scribes in Clinical Practice: A Randomized Trial. NEJM AI. 2025 Dec;2(12):10.1056/aioa2501000. doi: 10.1056/aioa2501000. Epub 2025 Nov 26. PubMed 41497288 ↗
  • Eileen Kim, M.D., Vincent X. Liu, M.D., M.Sc., and Karandeep Singh, M.D., M.M.Sc. AI Scribes Are Not Productivity Tools (Yet). NEJM AI. November 26, 2025;2(12)

Individual participant data

Plan to share: Yes — De-identified individual participant data (IPD) underlying the main published results may be shared with other researchers upon reasonable request to the principal investigator and after approval by the Hospital de Clínicas/UFPR data governance. The study protocol and statistical analysis plan will be made available as supplementary material. The analytic code (e.g., R/Python scripts) used for data cleaning and analysis will be deposited in a public Git repository (such as GitHub) after publication of the primary results.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: IPD will be made available after publication of the primary results and for at least 5 years thereafter.

Access criteria: Access will be granted to qualified researchers with a methodologically sound proposal, subject to data-use agreement and approval by the local ethics committee/IRB and the sponsor institution. Requests should be sent to the principal investigator (Gustavo Lenci Marques, Universidade Federal do Paraná).

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Nov 2026, 22 months after the start.

Of 253 non-industry interventional studies with no phase under Burnout, Psychological, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's planned 22 months is above that.

Counting every sponsor, half of 260 studies reached it within 12 months; a quarter within 5 and three quarters within 24.

Primary completion moved twice since we started tracking on Sep 25, 2026: Sep 2026 → Nov 2026, last on Nov 16, 2026.

Completion moved twice since we started tracking on Sep 25, 2026: Sep 2026 → Nov 2026, last on Nov 16, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 11, 2025
First posted
Dec 24, 2025
StartActual
Jan 5, 2025
Primary completionEst.
Nov 28, 2026was Sep 2026
CompletionEst.
Nov 28, 2026was Sep 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Sep 28, 2026→Nov 28, 2026
moved 2 times, Sep 30, 2026 – Nov 16, 2026
Study completion
Sep 28, 2026→Nov 28, 2026
moved 2 times, Sep 30, 2026 – Nov 16, 2026
Show all 2 updates
  1. Nov 16, 2026
    Primary completion Oct 28, 2026→Nov 28, 2026
    Study completion Oct 28, 2026→Nov 28, 2026
  2. Sep 30, 2026
    Primary completion Sep 28, 2026→Oct 28, 2026
    Study completion Sep 28, 2026→Oct 28, 2026

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07302906
Lead sponsor
Pedro Angelo Basei de Paula
Collaborators
Universidade Federal do Paraná
Responsible party
Pedro Angelo Basei de Paula (Research Coordinator, Universidade Federal do Paraná) — Sponsor-investigator
First posted
Dec 24, 2025
Start date
Jan 5, 2025
Primary completion
Nov 28, 2026 (estimated)
Completion
Nov 28, 2026 (estimated)
Last update
Nov 16, 2026

Study contacts

Gustavo Lenci Marques, MD, PhD
Contact
gustavolencimarques@gmail.com
+5541991491428
Gustavo Lenci Marques, MD, PhD
principal investigator · Universidade Federal do Paraná
Pedro Angelo Basei de Paula, Medical Student
study director · Universidade Federal do Paraná

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion